[1] Hunter GJ,Krauz M,Theek C,et al. Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimentional functional CT:early chinical results. A JNR,1998,19:29-37.
[2] 中华医学会肝病学分会和感染病学学会.慢性乙型肝炎防治指南. 实用肝脏病杂志,2006,9（1）：8-18.
[3] 中国中西医结合学会肝病专业委员会.肝纤维化中西医结合诊疗指南. 中西医结合肝病杂志,2006,16（5）：316-320.
[4] Zhu C,Sun Y,Luo X,et al. Novel mfg12 antisense plasmid inhibits murine fg12 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice.Hum Gene Ther,2006,17（6）:589-600.
[5] Gish RG,Lok AS,Chang TT,et al. Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.Gastroenterology,2007,133（5）:1437-1444.
[6] 姚光弼,任红,徐道振,等. 慢性乙型肝炎患者持续应用恩替卡韦治疗3年的疗效. 中华肝脏病杂志,2009,17（12）：881-886.
[7] 慢性乙型肝炎抗病毒治疗专家委员会.慢性乙型肝炎抗病毒治疗专家共识. 中华实验和临床感染病杂志（电子版）,2010,4（1）：82-91.
[8] Sharon A,Chu CK.Understanding the molecular basis of HBV drug resistance by molecular modeling. Antivir Res,2008,80（3）:339-353.
[9] 胡义杨,刘成梅.肝纤维化的中医药治疗和研究值得关注. 中西医结合肝病杂志,2008,18（1）：1-4.
[10] Cheng Y,Ping J,Liu C,et al. Study on effects of extracts from salvia miltiorrhiza and curcuma longa in inhibiting phosphorylated extracellular signal regulated kinase expression in rats hepatic stellate cells. Chin J Integr Med,2006,12（3）:207-211. |
